Consistent with our data, previous data also demonstrated that MHC expression was associated with therapeutic response to immunotherapy, better progression free survival, overall survival and CD4+ and CD8+ T cells tumor infiltrate in node-negative breast cancer 19, colorectal cancer 20 and melanoma 21. Here, CD8A is linked to neoplasm.